The Science of Addiction: Why Do People Get Hooked on Drugs?

The patients I see most often arrive believing they simply have weak willpower. They say things like, “I knew it was destroying me, and I kept going anyway.” That gap between knowing and stopping is not a moral gap. It is a neurological one. The prefrontal cortex, the part of the brain that weighs consequences, is one of the last regions to recover after chronic drug use, which is exactly why someone can clearly see the damage and still not stop.

What Actually Happens in the Brain When Someone Uses Drugs

Every drug of abuse, from heroin to cocaine to alcohol, triggers an enormous surge of dopamine in the nucleus accumbens, a small structure deep in the brain’s reward circuit. To put it in scale: sex and food raise dopamine by about 100-200% above baseline. Cocaine raises it by roughly 400%. Methamphetamine raises it by over 1,000%.

That surge is not pleasure, exactly. The neuroscientist Kent Berridge showed in landmark research that dopamine drives “wanting,” not “liking.” The hedonic pleasure of a drug, what you actually feel as enjoyable, is processed through opioid and endocannabinoid receptors in separate brain regions, including the ventral pallidum. Dopamine is the engine that makes you pursue it.

This distinction matters because it explains something families find baffling: why a person keeps using a drug even when it stops feeling good. The “wanting” system can escalate while the “liking” system stagnates or even reverses. The brain demands the drug without delivering the reward it originally promised.

How the Brain Changes With Repeated Drug Use

One dose does not cause addiction. But repeated doses trigger a process called neuroadaptation, and this is where the biology turns serious.

Dopamine Receptor Downregulation

The brain is an efficiency machine. When dopamine floods the nucleus accumbens repeatedly, the brain responds by reducing the number of D2 dopamine receptors available to receive the signal. This is called downregulation. The result is that the same dose produces a weaker effect, which is tolerance. To feel anything close to the original experience, you need more drug.

The same downregulation dulls your response to natural rewards. Food, relationships, and exercise all rely on the same dopamine circuitry. After prolonged drug use, these normal pleasures register as flat. This is why many people in early recovery describe a grey, joyless period before their brain begins to heal. We have a detailed explanation of what happens to dopamine sensitivity over time on our dopamine desensitisation page.

Prefrontal Cortex Impairment

The prefrontal cortex is responsible for impulse control, risk assessment, and the ability to choose a long-term benefit over a short-term reward. Chronic drug use physically degrades grey matter density in this region. Brain imaging studies using PET scans show reduced prefrontal metabolism in people with cocaine, methamphetamine, and opioid dependence compared to matched controls.

This is the neurological reason a person can say “I am done” on Monday and be using again by Thursday. The brain region that executes that decision is structurally compromised. Treatment that ignores this, and simply asks for willpower, is asking a person with a broken leg to run.

The Stress System and Withdrawal

The hypothalamic-pituitary-adrenal (HPA) axis regulates your stress response. Chronic drug use dysregulates this system so that the brain begins to require the drug just to maintain a normal emotional baseline. When the drug is absent, the stress system fires excessively. This is the neurochemical driver of craving during withdrawal and for months afterward.

Corticotropin-releasing factor (CRF), the key signalling molecule in this stress cascade, rises sharply during abstinence. It is the reason withdrawal does not feel like mere discomfort. It feels like dread and panic, because at a neurochemical level, the brain is in genuine alarm.

Why Some People Get Addicted and Others Don’t

This is the question families ask most often. Two people can try the same drug at the same age in the same circumstances, and one develops a severe use disorder while the other does not. The answer is not character. It is a combination of genetic loading, developmental timing, and environmental exposure.

Genetics Account for Roughly Half the Risk

Twin studies and genome-wide association research consistently place the heritability of substance use disorders at around 40 to 60 percent. This is comparable to the heritability of type 2 diabetes. Specific variants in genes governing dopamine receptor density, the COMT enzyme which clears dopamine from the prefrontal cortex, and the mu-opioid receptor (OPRM1 gene, A118G variant) all influence how powerfully rewarding a drug feels and how strongly the stress system reacts to its absence.

People with a first-degree relative with a severe substance use disorder carry roughly double the population risk. This is not destiny, but it is a meaningful signal.

Age of First Use

The prefrontal cortex does not finish developing until around age 25. During adolescence, the limbic reward system is highly active while the inhibitory braking system of the prefrontal cortex is still under construction. This neurological imbalance means that drugs used before age 15 produce stronger dopamine responses and more lasting receptor changes than the same drugs used in adulthood. Starting before 15 increases lifetime risk of developing a substance use disorder by a factor of four to five compared to starting after 21.

Mental Health and Self-Medication

Depression, anxiety, PTSD, and ADHD substantially increase addiction risk. The mechanism is not just psychological avoidance. It is often neurochemical. A person with ADHD has reduced dopamine tone in the prefrontal cortex. Stimulants temporarily normalise that deficit, which is why stimulant misuse is more common in undiagnosed ADHD. A person with PTSD has a hyperactive CRF stress system. Opioids and alcohol suppress that system directly.

Self-medication is a rational response to a real neurochemical deficit. It is also a path to dependence. Co-occurring mental health conditions must be treated alongside the addiction, not sequentially, or the substance use disorder will reliably return.

The Habit Loop vs. Compulsion: Why Addiction Is Not Just a Bad Habit

A common misconception is that addiction is simply a stubborn habit. Habits are automatic behaviours encoded in the dorsal striatum, a brain region that handles routine motor sequences. Breaking a habit requires forming a new routine to replace it. Addiction is different.

In addiction, the goal-directed decision to use a drug becomes gradually replaced by a stimulus-response compulsion controlled by the amygdala and dorsal striatum simultaneously. The cue, a place, a person, a smell, an emotional state, triggers automatic drug-seeking before conscious decision-making can intervene. This is why people with severe use disorders describe using “before they even decided to.” They are reporting something neurologically accurate.

Research at the Koob-Volkow model level, articulated clearly by George Koob and Nora Volkow, describes this as a three-stage cycle: binge and intoxication, withdrawal and negative affect, and preoccupation and anticipation. Each stage reinforces the next and is driven by different brain circuits. Understanding the brain changes in more detail, including how specific drugs affect each circuit, is covered in our piece on how drugs affect the brain.

Why Withdrawal Alone Does Not Explain Addiction

The competitor explanation that many people still believe is that withdrawal keeps people using because stopping feels terrible. This is partially true but mostly incomplete.

For heroin, acute physical withdrawal resolves within about a week to ten days. Most opioid users who relapse do so weeks or months after physical symptoms are gone. What persists is protracted abstinence syndrome, a prolonged state of low dopamine tone, elevated stress reactivity, and strong cue-triggered craving that can last six to eighteen months into recovery. This is driven by those receptor changes, not by acute withdrawal.

For stimulants like cocaine and methamphetamine, there is no dramatic physical withdrawal comparable to opioids at all. Yet stimulant addiction is severe and relapse rates are high. Withdrawal alone cannot explain this. Craving driven by conditioned dopamine responses to drug-associated cues does.

The Role of Trauma and Adverse Childhood Experiences

The ACE (Adverse Childhood Experiences) study, one of the largest investigations of its kind, found a dose-response relationship between childhood trauma and addiction risk. A person with an ACE score of four or more is seven times more likely to report injected drug use than someone with an ACE score of zero.

The mechanism is the HPA axis again. Childhood trauma shapes stress response systems during a critical developmental window. Adults with high ACE scores have chronically elevated cortisol reactivity and blunted dopamine function at baseline. Drugs that suppress the stress system or spike dopamine provide genuine, powerful neurochemical relief. This is not weakness. It is a predictable response of a trauma-shaped nervous system.

This is why effective addiction treatment must address underlying trauma. Detox without trauma-informed care produces short recovery windows before relapse. Behavioural therapies such as EMDR, somatic therapy, and trauma-focused CBT target the dysregulated HPA axis directly. If you want to understand somatic approaches in more detail, our article on somatic therapy and addiction covers this well.

Involuntary Addiction: When Prescribed Medications Lead to Dependence

Not everyone who becomes addicted sought a high. The opioid crisis in North America produced large numbers of people who developed dependence after being prescribed opioids for legitimate pain, by doctors, for medically sanctioned reasons.

Oxycodone, hydrocodone, and fentanyl are effective analgesics. They also trigger substantial dopamine release in the nucleus accumbens. A patient using them for post-surgical pain is not seeking pleasure. But the same neuroadaptive changes occur regardless of motivation. Tolerance develops. The HPA axis recalibrates around the drug. When the prescription ends, the brain experiences acute withdrawal and the person may seek the drug to relieve genuine neurochemical distress, not to get high.

This pattern is important because it dismantles the moral narrative around addiction entirely. The same brain changes occur whether the first use was recreational or prescribed. Treatment should never be withheld or made more difficult to access based on how the addiction started.

The clinical pattern that warrants attention is not how often someone uses, but what happens when they try to stop or cut down. The DSM-5 criteria for substance use disorder include using more than intended, unsuccessful attempts to cut down, continued use despite clear harm, and giving up important activities to use. Two or more of eleven criteria over a 12-month period qualifies as a substance use disorder, with severity rated mild, moderate, or severe based on how many criteria are met.

If you or someone you care about recognises this pattern, Phuket Island Rehab offers medically supervised detox and residential treatment that addresses both the neurobiology of addiction and the underlying trauma or mental health conditions driving it. Located in Thailand with an international medical team, it provides a level of evidence-based care that is difficult to access in many home countries, often at a fraction of the cost.

Drug addiction develops because repeated substance use triggers profound and progressive changes in the brain’s reward, stress, and decision-making circuits. Dopamine receptor downregulation dulls the pleasure of everyday life and drives escalating use. Prefrontal cortex damage impairs the ability to choose long-term wellbeing over short-term relief. The HPA stress axis recalibrates around the drug so that its absence feels neurochemically catastrophic. None of this is moral failure. It is predictable neuroscience. Genetics account for roughly half of addiction risk, early first use compounds that risk substantially, and untreated mental health conditions, especially those rooted in childhood trauma, create the neurochemical conditions that make certain substances feel like the only relief available.

Practically, this means that effective treatment must do more than remove the drug. It must address receptor recovery, stress system recalibration, trauma, and the conditioned cue responses that persist long after physical withdrawal resolves. Willpower-only approaches fail because they do not target the underlying biology. Medication-assisted treatment, trauma-informed care, and structured behavioural therapy together produce meaningfully better outcomes than any one approach alone. Recovery is possible, but it requires treating addiction as the medical condition it actually is.

As John A. Smith of Phuket Island Rehab puts it: “The patients who finally make progress are the ones who stop fighting themselves for being ‘weak’ and start asking what their brain actually needs to heal. That shift, from self-blame to clinical curiosity, is usually where real recovery begins.”

Why do people get addicted to drugs but not everyone who tries them?

Genetic variation accounts for roughly 40 to 60 percent of addiction risk, meaning two people can use the same drug and have very different neurological responses. Variants in dopamine receptor genes, the OPRM1 opioid receptor gene, and the COMT enzyme influence how powerfully rewarding a drug feels and how strongly the stress system reacts when it is absent. Age of first use, mental health history, and childhood trauma exposure compound or reduce that genetic baseline risk.

Is drug addiction a choice or a disease?

The first use of a drug typically involves a degree of choice, but the development of addiction involves progressive changes to brain structure and function that move well beyond voluntary control. The DSM-5 classifies substance use disorder as a medical condition, and brain imaging consistently shows reduced prefrontal grey matter and dopamine receptor density in people with severe use disorders, changes that impair the very neural systems needed to make and execute a decision to stop. Describing addiction purely as a choice ignores the neuroscience and makes effective treatment harder to access.

What makes drugs so addictive compared to other pleasurable activities?

Drugs bypass the brain’s normal reward calibration by flooding the nucleus accumbens with dopamine at magnitudes natural rewards cannot produce. Food and sex raise dopamine by roughly 100 to 200 percent above baseline; cocaine raises it by around 400 percent; methamphetamine by over 1,000 percent. This unnatural surge creates conditioned associations so powerful that ordinary rewards register as inadequate by comparison, and the brain increasingly directs attention and motivation toward the drug at the expense of everything else. Behavioural addictions can engage the same circuits, as described in our overview of how behavioural addictions rewire the brain.

Why do people relapse even after months of being clean?

Relapse after months of abstinence is driven primarily by two mechanisms: protracted abstinence syndrome and conditioned cue reactivity. Protracted abstinence syndrome is a prolonged state of low dopamine tone and heightened stress reactivity that can persist for six to eighteen months after stopping, driven by slow receptor recovery. Conditioned cue reactivity means that people, places, emotional states, and sensory triggers associated with past drug use can provoke a dopamine surge and intense craving long after physical withdrawal is resolved, activating drug-seeking before conscious decision-making can intervene.

Can addiction be cured, or is it lifelong?

Addiction is best understood as a chronic, manageable condition rather than something that is either cured or permanent. Many people achieve sustained, long-term remission with appropriate treatment and the brain does recover substantially over time, including partial restoration of dopamine receptor density and prefrontal function. The risk of relapse does not disappear entirely, particularly under high stress or exposure to conditioned cues, which is why ongoing support, aftercare planning, and monitoring remain important components of long-term recovery.

Why do teenagers get addicted faster than adults?

The adolescent brain is neurologically primed for risk-taking and reward-seeking because the limbic system matures before the prefrontal cortex, which is not fully developed until approximately age 25. This means the reward signal from drugs is stronger and the inhibitory braking system is weaker during the teenage years. Drug use before age 15 produces more lasting changes to dopamine receptor systems than equivalent use in adulthood, and epidemiological data consistently shows a four to fivefold increase in lifetime substance use disorder risk for early-onset users.

What is the connection between trauma and drug addiction?

Childhood trauma physically alters the hypothalamic-pituitary-adrenal stress axis during a critical developmental window, producing adults with chronically elevated cortisol reactivity and reduced baseline dopamine function. Drugs that suppress the stress system or spike dopamine provide genuine neurochemical relief for a nervous system shaped by trauma, which is why self-medication is so common among people with high ACE scores. Treating addiction without addressing underlying trauma produces reliably poor outcomes, because the neurochemical conditions driving use remain unchanged.